Stay updated with breaking news from Praxis Precision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Friday, Benzinga reports. They presently have a $105.00 price objective on the stock. HC Wainwright’s target price indicates a potential upside of 91.61% from the company’s previous close. PRAX […]
Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) traded down 6.1% on Wednesday . The company traded as low as $51.82 and last traded at $52.18. 81,782 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 213,917 shares. The stock had previously closed at $55.57. […]
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $105.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 77.54% from the stock’s current price. A […]
Shares of Praxis Precision Medicines, Inc. (PRAX) jumped over 26% on Tuesday morning after the company reported positive results from a phase 2 study of epilepsy treatment.
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its target price boosted by equities researchers at Jefferies Financial Group from $75.00 to $128.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s price objective points to a potential upside […]